531 related articles for article (PubMed ID: 28135101)
1. Design and Investigation of a [
Yang D; Comeau A; Bowen WD; Mach RH; Ross BD; Hong H; Van Dort ME
Mol Pharm; 2017 Mar; 14(3):770-780. PubMed ID: 28135101
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of 4 and 6-carbon spacer conformationally flexible tetrahydroisoquinolinyl benzamide analogues for imaging the sigma-2 receptor status of solid tumors.
Lee I; Lieberman BP; Li S; Hou C; Makvandi M; Mach RH
Nucl Med Biol; 2016 Nov; 43(11):721-731. PubMed ID: 27589334
[TBL] [Abstract][Full Text] [Related]
3. Fluorine-18-labeled benzamide analogues for imaging the sigma2 receptor status of solid tumors with positron emission tomography.
Tu Z; Xu J; Jones LA; Li S; Dumstorff C; Vangveravong S; Chen DL; Wheeler KT; Welch MJ; Mach RH
J Med Chem; 2007 Jul; 50(14):3194-204. PubMed ID: 17579383
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro binding, and tissue distribution of radioiodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodo benzamide, 2-[125I]BP: a potential sigma receptor marker for human prostate tumors.
John CS; Gulden ME; Li J; Bowen WD; McAfee JG; Thakur ML
Nucl Med Biol; 1998 Apr; 25(3):189-94. PubMed ID: 9620622
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
[TBL] [Abstract][Full Text] [Related]
6. Development of
Potemkin R; Strauch B; Kuwert T; Prante O; Maschauer S
Mol Pharm; 2020 Mar; 17(3):933-943. PubMed ID: 32011889
[TBL] [Abstract][Full Text] [Related]
7. Preliminary evaluation of a novel
Zhou D; Xu J; Mpoy C; Chu W; Kim SH; Li H; Rogers BE; Katzenellenbogen JA
Nucl Med Biol; 2018 Nov; 66():26-31. PubMed ID: 30195072
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacological evaluation of ¹¹C-labeled piperazine derivative as a PET probe for sigma-2 receptor imaging.
Selivanova SV; Toscano A; Abate C; Berardi F; Müller A; Krämer SD; Schibli R; Ametamey SM
Nucl Med Biol; 2015 Apr; 42(4):399-405. PubMed ID: 25637276
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pre-clinical evaluation of a new class of high-affinity
Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991
[TBL] [Abstract][Full Text] [Related]
10. Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.
John CS; Vilner BJ; Geyer BC; Moody T; Bowen WD
Cancer Res; 1999 Sep; 59(18):4578-83. PubMed ID: 10493511
[TBL] [Abstract][Full Text] [Related]
11.
Ye J; Wang L; Deuther-Conrad W; Chen Y; Zhang X; Zhang J; Huang Y; Brust P; Jia H
J Labelled Comp Radiopharm; 2019 Jun; 62(8):425-437. PubMed ID: 30991462
[TBL] [Abstract][Full Text] [Related]
12. Design, Radiosynthesis and Preliminary Biological Evaluation in Mice of a Brain-Penetrant
Moldovan RP; Gündel D; Teodoro R; Ludwig FA; Fischer S; Toussaint M; Schepmann D; Wünsch B; Brust P; Deuther-Conrad W
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064122
[TBL] [Abstract][Full Text] [Related]
13. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of a 18F-labeled spirocyclic piperidine derivative as promising σ1 receptor imaging agent.
Chen YY; Wang X; Zhang JM; Deuther-Conrad W; Zhang XJ; Huang Y; Li Y; Ye JJ; Cui MC; Steinbach J; Brust P; Liu BL; Jia HM
Bioorg Med Chem; 2014 Oct; 22(19):5270-8. PubMed ID: 25189691
[TBL] [Abstract][Full Text] [Related]
15. Preclinical Evaluation and Pilot Clinical Study of Al
Liu T; Liu C; Xu X; Liu F; Guo X; Li N; Wang X; Yang J; Yang X; Zhu H; Yang Z
J Nucl Med; 2019 Sep; 60(9):1284-1292. PubMed ID: 30796170
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of fluorine-18-labeled SA4503 as a selective sigma1 receptor ligand for positron emission tomography.
Kawamura K; Tsukada H; Shiba K; Tsuji C; Harada N; Kimura Y; Ishiwata K
Nucl Med Biol; 2007 Jul; 34(5):571-7. PubMed ID: 17591557
[TBL] [Abstract][Full Text] [Related]
17. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M
J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139
[TBL] [Abstract][Full Text] [Related]
18. Substituted halogenated arylsulfonamides: a new class of sigma receptor binding tumor imaging agents.
John CS; Lim BB; Vilner BJ; Geyer BC; Bowen WD
J Med Chem; 1998 Jul; 41(14):2445-50. PubMed ID: 9651150
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vivo evaluation of [18F]N-(2-benzofuranylmethyl)-N'-[4-(2-fluoroethoxy)benzyl]piperazine, a novel σ1 receptor PET imaging agent.
Moussa IA; Banister SD; Giboureau N; Meikle SR; Kassiou M
Bioorg Med Chem Lett; 2011 Nov; 21(22):6820-3. PubMed ID: 21962578
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Evaluation of
Cardinale J; Schäfer M; Benešová M; Bauder-Wüst U; Leotta K; Eder M; Neels OC; Haberkorn U; Giesel FL; Kopka K
J Nucl Med; 2017 Mar; 58(3):425-431. PubMed ID: 27789722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
